[科学研究和技术服务业] [2025-02-26]
The human microbiome is the aggregate of all microbiota that reside on or within human tissues and biofluids. Changes in the composition and concentration of the microbiome can lead to the development of gastrointestinal and non-gastrointestinal diseases. The global microbiomes market covers microbiome-based therapeutic and diagnostic products that are developed using the information obtained from relational studies between human microbiota and human diseases.
[医药制造业,科学研究和技术服务业] [2025-02-25]
A humanized mouse model is an organism that has been genetically engineered to study immune responses to drugs or identify potential disease targets.
[科学研究和技术服务业,信息传输、软件和信息技术服务业,租赁和商务服务业] [2025-02-24]
Gym management software manages marketing campaigns, membership records, billing, scheduling, reporting, and analytics in a gym. It is available in the cloud and on-premises deployment models.
[科学研究和技术服务业,信息传输、软件和信息技术服务业,租赁和商务服务业] [2025-02-24]
Gym management software manages marketing campaigns, membership records, billing, scheduling, reporting, and analytics in a gym. It is available in the cloud and on-premises deployment models.
[科学研究和技术服务业] [2025-02-24]
The global genomics market includes the use of genomics products, such as consumables and instruments and services, to study genes, genetic functions, and related technologies. Genomics addresses the study of all the genes and their inter-relationship to identify their combined influence on the growth and development of organisms. The information obtained through genomics studies is used in the identification of any variations and mutations in the genomics structure, which helps in developing diagnostic methods for genetic diseases and their targeted treatments.
[信息传输、软件和信息技术服务业,科学研究和技术服务业] [2025-02-22]
A fitness app is a digital application typically accessed via smartphones or other devices, offering users a range of tools and resources to support their physical health and fitness goals. These apps often include features such as workout plans, exercise routines, activity tracking, nutritional guidance, goal setting, progress tracking, and community support.
[医药制造业,科学研究和技术服务业] [2024-12-31]
cleaning roducts ave eco e art and arcel o a consu er’s life. Consumer awareness is also growing every year, which is why manufacturers are focusing on elevating the quality of cleaning products with the best possible environmental conditions. Today's consumer is not just concerned about maintaining hygiene or cleanliness at a personal level but is also keen on reducing the chances of infections in his/her surroundings. So, to fulfill the hygiene needs at home as well as at commercial places, different ingredients are used in cleaning products.
[科学研究和技术服务业] [2024-12-31]
Laboratory glassware stands as a cornerstone of scientific research, experimentation, and analysis. Its crucial role in maintaining precision, accuracy, and reliability within diverse industries highlights its significance in advancing knowledge and technological progress. The laboratory glassware market, driven by an amalgamation of scientific advances, evolving research needs, and technological innovation, is a vital enabler of breakthroughs and discoveries across various sectors.
[科学研究和技术服务业,信息传输、软件和信息技术服务业] [2024-12-26]
Biometric POS terminals comprise point-of-sale (POS) devices that use biometrics-based data like fingerprints, retina scans, or even facial recognition to authenticate the identity of a customer or employee. These terminals replace PINs or passwords to verify the identity of the individual. Biometric POS terminals are often used to prevent fraud and theft or in key industries where security is critical. The retail, medical and healthcare, food service (restaurants), financial, logistics, government, and entertainment industries are some of the major end-users of biometric POS terminals.
[科学研究和技术服务业] [2024-12-20]
经过全球产业分工,印度和中国基于各自比较优势成为世界主要原料药供应 国,印度仿制药在全球崛起既有历史机遇亦是产业升级的结果。从投资回报 来看,大部分印度制药股票走出长牛趋势,印度制药 Nifty Pharma 指数在 2001.01~2024.11 期间总回报 2406%,二十四年的年化收益率 14.41%,而 不少龙头企业的市场表现更为亮眼,如 Sun Pharma 在 2001.01~2024.11 期 间,股价上涨 146 倍,总回报 17351%(含股利),二十四年的年化收益率 高达 24.08%,远跑赢 Nifty Pharma 和印度大盘 Sensex 指数。